Events

Webinar on Manufacturing Data Spaces Call
DEC
Wed
07
09:30 - 12:00

This was 2 years ago

Location

Online

Programmes
AI Continent

The European Factories of the Future Research Association and the European Commission (DG Connect) are organising this webinar specifically focusing on the open call on manufacturing data spaces.

After a presentation of the Common European Data Spaces in general, the call for Manufacturing Data Spaces will be explained in detail and participants will have the opportunity to ask questions.

During the webinar the Data Spaces Support Centre and the Manufacturing Data Spaces CSA will also be presented.

More information and the possibility to register on the event website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.